PulmoCare and Medtronic Celebrate Soaring Sales of Bipolar Temporary Pacing Catheter After One Year of Strategic Collaboration
Medtronic
Medical Device Manufacturer
Soaring Performance!
Bipolar Temporary Pacing Catheter Delivers Satisfactory Results
At 11:00 a.m. on March 15th, at the Medtronic booth during the China Medical Equipment Conference and the 2025 Medical Equipment Exhibition in China, there was an atmosphere filled with joy and excitement as a grand celebration ceremony was taking place.
Attendees (from left to right): Peitao Zhang from Medtronic, Song Lin, Robert Kowal, Mr. Hua Chen (third from the right), and Ms. Peizhi Ni (first from the right).Ms. Lai Chunhong (fourth from the right) and Mr. Liu Xin (second from the right) from Probo Medical
The protagonist, "Bipolar Temporary Pacing Catheter," was placed center stage, basking in the limelight.
After a year of close cooperation between the two parties, the sales performance of bipolar temporary pacing catheters soared, and the "Medtronic + Pubo Temporary Pacing Therapy Solution" has gained increasing trust and recognition from more and more users!
The strategic cooperation that began at last year's China Medical Equipment Conference has delivered an exceptionally satisfactory outcome today.
Sincere Cooperation, Abundant Results
Originating from the初心 of "promoting the widespread adoption of temporary pacing therapy to ensure more patients receive timely and effective treatment," the sincere collaboration between the two parties has not only allowed us to witness explosive growth in sales performance but also yielded fruitful results in technological innovation, market expansion, and other aspects, earning widespread recognition from doctors and patients worldwide.
Primo Medical, as a leading provider of critical care solutions in China, offers efficient, precise, and intelligent closed-loop medical services for critical emergencies to thousands of medical institutions in over 100 countries worldwide, covering fields such as life support, medical consumables, medical imaging, information-based healthcare, and home healthcare.
Bipolar Temporary Pacing Catheter, Global Sales Over 500,000 Sets
The Primo Bipolar Temporary Pacing Catheter, originating from Singapore's Bioptimal (formerly Biosensors), which has 36 years of innovation in medical devices, has been certified in China, Europe, Japan, and other national-level regions, and is widely used by thousands of clinical users.As of January 18, the global sales of MicroPort's bipolar temporary pacing catheter have exceeded 500,000 sets!
Medtronic, the global leader in medical technology, covers more than 70 key disease areas with its innovative medical technologies. Since entering China 35 years ago, Medtronic has introduced over 700 products to the Chinese market. The Medtronic temporary pacemaker is renowned worldwide for its advanced technology, reliability, and patient adaptability, becoming an important treatment option for arrhythmia patients globally.
Accelerate the下沉of high-quality medical resources to benefit millions
This innovative collaboration between the two parties has accelerated the localization process of temporary pacing therapy in China, expedited the dissemination of quality medical resources, and promoted the standardized and scientific operation and application of temporary cardiac pacing therapy among a broader patient population.
Looking ahead, Puhbo Medical and Medtronic will continue to deepen their cooperation and explore more future collaboration opportunities. The two parties plan to expand the technical exchange platform, promote the development of innovative technologies, and develop more advanced medical devices tailored to the needs of the Chinese market.
In addition, the two parties will also explore new market promotion strategies and optimize supply chain management to improve the market response speed and service quality of the products. This ongoing cooperation will not only drive the further development of both parties' businesses but also make a greater contribution to the treatment of cardiovascular diseases and the popularization of emergency care in China and even globally.